Alnylam Pharmaceuticals
ALNY
#700
Rank
ยฃ27.75 B
Marketcap
ยฃ207.87
Share price
-3.12%
Change (1 day)
-8.68%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company